Kelly H Mroz

Ms. Kelly H Mroz


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Akira SekikawaAkira Sekikawa
Akira Sekikawa
AWAshley Weaver
Ashley Weaver
KMKelly H Mroz
Kelly H Mroz
NHNina Z. Heilmann
Nina Z. Heilmann
DFDiana Alejandra Madrid Fuentes
Diana Alejandra Madrid Fuentes
JCJane A Cauley
Jane A Cauley
Background/Objectives: Osteoporosis is highly prevalent and contributes substantially to morbidity and mortality, yet long-term concerns about pharmacologic therapies leave a major treatment gap. Soy isoflavones have been investigated as safer alternatives, but results across trials are inconsistent. A key unresolved issue is the equol-producer phenotype, the gut microbial ability to convert daidzein to S-equol, the most bioactive isoflavone metabolite, which may explain much of this variability. This narrative review synthesizes mechanistic, translational, and clinical evidence to clarify the potential skeletal relevance of S-equol. Methods: Literature was identified through PubMed and Scopus searches (January 2000–October 2025) for experimental, mechanistic, and clinical studies examining S-equol, estrogen receptor β (ERβ), and bone metabolism, with emphasis on equol-producing status, bone strength and bone microarchitecture. Results: S-equol acts as a high-affinity ERβ agonist with antioxidant and anti-inflammatory properties but lacks the carcinogenic or thrombotic risks linked to ERα activation. In estrogen-deficient rodent models, S-equol improves trabecular bone volume by 10–20%, increases trabecular number, and enhances biomechanical strength. These findings align with preclinical evidence demonstrating that S-equol preserves trabecular microarchitecture, enhances bone strength, and reduces bone turnover. A limited number of human trials show reductions in bone resorption by 20% at a daily dose of 10 mg S-equol. In contrast, trials of soy isoflavones in humans have produced inconsistent findings, partly because of substantial variability in equol-producer phenotype among participants and the reliance on dual-energy X-ray absorptiometry, which cannot distinguish trabecular from cortical compartments. Advanced bone imaging and microbiome-informed approaches enable the precise evaluation of S-equol’s skeletal effects on trabecular bone and cortical bone, separately. Conclusions: S-equol represents a promising model for “precision nutrition,” where microbiome, hormonal, and host factors converge with potential to prevent age-related bone fragility. Rigorous trials that integrate microbiome phenotyping and advanced imaging are needed to validate this approach, translate mechanistic promise into clinical benefit, and better define safety.

15 August 2026 in Clinical Biomechanics
Verified
Journal Article
Closed access
PPPaige Paulus
Paige Paulus
TGTom Gale
Tom Gale
RSRishabh Shetty
Rishabh Shetty
YYYulia Yatsenko
Yulia Yatsenko
JEJustin Elder
Justin Elder
WAWilliam Anderst
William Anderst

18 August 2026 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
KMKelly H Mroz
Kelly H Mroz
LWLivia G. Wunderlich
Livia G. Wunderlich
KKKristen J. Koltun
Kristen J. Koltun
ASAdam J. Sterczala
Adam J. Sterczala
NSNicole M. Sekel
Nicole M. Sekel
BNBradley C. Nindl
Bradley C. Nindl
Multidirectional sports introduce unique forces to the tibia that potentially induce more symmetrical distribution of bone mass and lower bone stress injury risk, when compared with unidirectional sports. Purpose: To compare tibial shaft size, shape, and estimated strength among competitive male and female athletes in sports with different loading demands. Methods: High-resolution peripheral quantitative computed tomography (HR-pQCT) scans of the tibial diaphysis (30% site) were performed in 149 NCAA Division I male and female cross-country and basketball athletes, female gymnastics and lacrosse athletes, and male American football athletes playing the wide receiver position. Tibial shaft outcomes relating to bone shape (ratio of the maximum and minimum moments of area [Imax/Imin]), size, and strength were compared by sport within each sex. Bone size outcomes were scaled to bone length to adjust for allometry. Kruskal–Wallis tests estimated group differences. Results: In female athletes, gymnastics had a 13.5% lower Imax/Imin than cross-country (median [IQR] = 1.7 [1.4–1.9] vs 2.0 [1.8–2.2], P = 0.041) indicating a more symmetrical distribution of bone. In male athletes, football had the lowest Imax/Imin of all sports evaluated (median [IQR] = 1.6 [1.4–1.8]), although this did not reach significance ( P = 0.051). There were no differences in tibial shaft outcomes between female gymnastics athletes or male football athletes and sex-matched basketball athletes ( P > 0.196). There were also no differences between female lacrosse and cross-country athletes ( P > 0.500). Conclusions: The contributions of multidirectional sports on tibial shaft characteristics are nuanced, and high-impact loading may be necessary to develop a more symmetrical shape, which may influence tibial bone stress injury risk.

14 September 2026 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
KMKelly H Mroz
Kelly H Mroz
JGJenna B. Goulart
Jenna B. Goulart
ASAdam J. Sterczala
Adam J. Sterczala
LWLivia G. Wunderlich
Livia G. Wunderlich
NSNicole M. Sekel
Nicole M. Sekel
KKKristen J. Koltun
Kristen J. Koltun
Was not provided for this article.